InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Khouri, Amal. Director active across 1 company, notably Knight Therapeutics Inc.. Cumulatively, 2 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €6k. History available since 15 June 2026. The latest transaction was filed on 15 June 2026 (30 - Acquisition or disposition under a purchase/ownership plan). Regulator: SEDI. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations